a recent Fact study of the market. According to MR, the global respiratory syncytial virus (RSV) diagnostics market will generate US$ 1.3 Bn in revenue by 2031, growing at a 9% CAGR. By the end of 2031, the market for RSV diagnostic kits and assays is expected to reach a value of US$720 Mn.Rising RSV infection rates, rising demand for molecular diagnostic tests, and rising approvals of RSV diagnostic kits & assays are just a few of the many factors credited with accelerating demand for respiratory syncytial virus diagnostics.
The offer in this portion accompanies many open doors including fabricating items, appropriation, retail, and showcasing administrations. Broad rounds of essential and a far reaching optional exploration have been utilized by the examiners at Fact.MR to show up at different assessments and projections for Demand of Respiratory Syncytial Virus (RSV) Diagnostics Market both at worldwide and provincial levels.
Download Sample Copy of This Report: –https://www.factmr.com/connectus/sample?flag=S&rep_id=6736?PJ
Key Companies Profiled
- Abbott Laboratories
- Becton
- Dickinson and Company
- BioMérieux SA
- Bio-Rad Laboratories
- Coris BioConcept
- DiaSorin Molecular LLC (DiaSorin Inc)
- F. Hoffmann-La Roche AG
- Merck KgaA
- Quest Diagnostics Incorporated
- Quidel Corporation
- Thermo Fisher Scientific
Competitive Landscape
The respiratory syncytial virus diagnostics landscape is highly fragmented in nature. Manufacturers are focusing on technological innovations for speeding up the diagnosis of the respiratory syncytial virus.
Frequent mergers and acquisitions also take place in the market. The acquisition of Sigma Aldrich by Merck KGaA is a classic example.
Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research
- By Technology
- RSV Molecular Diagnostics
- RSV Monoclonal Antibodies
- Immunoassays
- Differential Light Scattering
- Artificial Intelligence
- Liposomes
- Flow Cytometry
- Chromatography
- Diagnostic Imaging
- Gel Microdroplets
- By End Users
- Respiratory Syncytial Virus Diagnostics at Hospitals
- Respiratory Syncytial Virus Diagnostics at Nursing Homes
- Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
- Respiratory Syncytial Virus Diagnostics at Public Health Laboratories
Why is Demand for Molecular Testing of RSV Infections on the Rise?
Demand for molecular testing of RSV infections is increasing in hospitals and reference laboratories. Moreover, a number of Clinical Laboratory Improvement Amendment (CLIA) waivers and U.S. FDA clearances are supporting the adoption of molecular diagnostic tests in physician offices and urgent care clinics.
Since RSV infections have a higher prevalence among infants and young children, adoption of molecular diagnostics is increasing as compared to immunoassays in this patient group
Key Points Covered in Respiratory Syncytial Virus Diagnostics Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis
- COVID-19 Impact on Demand for Respiratory Syncytial Virus Diagnostics and How to Navigate
- Recommendation on Key Winning Strategies